Address: Ground Floor, Building 5, Tuscany Office Park, 6 Coombe Place, Rivonia, 2129, Johannesburg, South Africa
Tel: +2711 2345701/2
Web: http://accord-healthcare.com/
A wholly owned subsidiary and the marketing arm of Intas Pharmaceuticals Ltd., India Accord is engaged in all the licensing related activities and pharmaceutical product trading in various Therapeutic Segments in the regulatory markets. The company leverages the manufacturing support from INTAS.
Accord Healthcare has its global matrix spread to USA, UK, Spain, Canada, Australia & New Zealand, South Africa, Brazil, Mexico, Peru, Vietnam, and Kenya.
Accord is committed to maximise customer satisfaction by introducing innovative, quality products in the market.
Accord Healthcare South Africa specializing in Oncology products as well as having a basket of products in the following therapeutic areas:
Biologicals, Immunosuppression, Cardio Vascular, Central Nervous System, Anti-diabetic, Nausea, Osteoporosis, Autonomic, Respiratory, GIT, Ophthalmics and Dermatologicals.
Clonazepam
Mycophenolate Mofetil
Levetiracetam Tablets
Lenias Hwenda of Medicines for Africa examines the true impact of access to medicine initiatives in Africa, noting that many of the measures takes are often cosmetic and leave a…
Some of the top pharma news coming out of South Africa including Afrigen’s partnership with US National Institutes of Health (NIH), BioNTech’s efforts to bring an mRNA start-to-finish vaccine manufacturing network…
David Mukanga of the Bill and Melinda Gates Foundation gives an overview of the latest developments on the long road towards the creation of an African Medicines Agency and the…
Kelly Chibale, founder of the H3D Centre at the University of Cape Town and chairman & CEO of the H3D Foundation, outlines the rationale behind the establishment of these institutions,…
Medicines for Africa’s Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the population has been vaccinated. Hwenda argues that…
Three months after the World Bank announced a EUR 600 million loan to South Africa’s Aspen Pharmacare, the African continent has received more good news as it seeks to increase…
In a notable first, following successful pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health Organization (WHO) has recommended that the RTS,S malaria vaccine be rolled out across…
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and Entos Pharma’s approval for Phase II clinical rials…
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government institutions from the USA, Germany, and France – has intervened to loan South African…
The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in international financial aid, Adcock Ingram’s disappointing results as fewer…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed commercial manufacture of their COVID-19 vaccine candidate, Ad26.COV2-S, boosting the company’s share…
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions…
See our Cookie Privacy Policy Here
